Drug intelligence / Profile preview

ibuprofen + ondansetron + misoprostol

Development stage
Unknown
Lead developer
Boots
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Sublingual, Buccal, Vaginal, Rectal
01

Overview

This is a combination of three small molecule drugs—ibuprofen, ondansetron, and misoprostol—used adjunctively in the context of medication abortion or for managing pain and gastrointestinal side effects associated with uterine procedures. - **Ibuprofen** is a nonsteroidal anti-inflammatory drug (NSAID) that acts as an analgesic and antipyretic by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis involved in pain, inflammation, and fever. - **Ondansetron** is a selective serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting by blocking serotonin receptors centrally in the chemoreceptor trigger zone and peripherally on vagal nerve terminals. - **Misoprostol** is a synthetic prostaglandin E1 analog that binds to prostaglandin E1 receptors on gastric parietal cells to reduce acid secretion, increase mucus/bicarbonate production for mucosal protection, and stimulate uterine contractions by binding smooth muscle cells in the uterus. In clinical practice, this combination is not available as a single commercial product but may be prescribed together during medication abortion regimens (with mifepristone) to manage cramping (ibuprofen), prevent or treat nausea/vomiting (ondansetron), and induce uterine contractions/expulsion of pregnancy tissue (misoprostol)[1][3][7][8]. Each component has distinct mechanisms but complementary roles in improving patient comfort during medical abortion.

02

Targets

PTGER2 (Prostaglandin E2 receptor EP2)PTGER3 (Prostaglandin E2 receptor EP3 subtype)PTGER4 (Prostaglandin E2 receptor EP4 subtype)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on ibuprofen + ondansetron + misoprostol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + ondansetron + misoprostol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call